Fragile X Society – BALKANS- Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
- Best Practices in Fragile X Syndrome Treatment Development
- Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment
- The fragile X syndrome-autism comorbidity: what do we really know?
- Q&A With Dr. Hagerman: Exploring the Fragile X Syndrome / Autism Link
- FXCRC Consensus Document: Autism Spectrum Disorder in Fragile X Syndrom
- The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
- Fragile X-Associated Neuropsychiatric Disorders (FXAND)
- New Targeted Treatments for Fragile X Syndrome
- Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals
- Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
- Fragile X targeted pharmacotherapy: lessons learned and future directions
- Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin–two cases
- FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia
- New Finding on Early Detection and Early Intervention in Autism Spectrum Disorder — Information and Resources for Parents and Providers
- Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
- Fragile X syndrome: leading the way as the most common monogenic form of autism spectrum disorder and the most translated among neurodevelopmental disorders in clinical trials
- Fragile X Gene Premutation: To Recognize Early and Treat Neuropsychiatric Problems